Getting out in front of disease is the ultimate goal of DNA screening like the BabySeq project, says Dr. Robert Green, its joint director and a Harvard Medical School professor.
Listen to WBUR’s radio segment on the BabySeq Project and one of its publications.
Conducting whole-exome sequencing on newborn babies during the BabySeq project highlighted important findings on how it would affect parents. While some were willing to know the information that was coded in their baby’s genes, many were resistant to this idea because of public policy and possible insurance mishaps.
A family that had participated in the BabySeq project shares their experiences about getting their baby’s full genome test results back that showed a mutation in the elastin proteins (elastin helps heart muscles bend and stretch). The father of the baby states “.. I think the biggest regret would have been had something happened down … Continued
With the cost of sequencing your genome going down by thousands of dollars, one man was able to combat his chronic pain by having his genome sequenced. But does having that knowledge always mean a better outcome?
An extremely interesting case study and audio report by journalist David Epstein tells the story of Jill Viles, who has muscular dystrophy and can’t walk. But she believes that she somehow has same condition as one of the best hurdlers in the world, Priscilla Lopes-Schliep. Epstein reaches out to Dr. Robert Green for professional medical … Continued
Dr. Robert Green shares his insight on the 23andMe initiative and what people should know from these results. “I think this is something that has to be monitored as these services expand their market to less-sophisticated individuals.”
Jason Vassy discusses President Obama’s State of the Union address in which he emphasized personalized medicine.